These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 19148563

  • 21. The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.
    Frost ML, Cook GJ, Blake GM, Marsden PK, Fogelman I.
    J Clin Densitom; 2007; 10(1):46-54. PubMed ID: 17289526
    [Abstract] [Full Text] [Related]

  • 22. Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis.
    Tran BN, Nguyen ND, Eisman JA, Nguyen TV.
    BMC Med Genet; 2008 Jun 27; 9():55. PubMed ID: 18588671
    [Abstract] [Full Text] [Related]

  • 23. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
    Agueda L, Bustamante M, Jurado S, Garcia-Giralt N, Ciria M, Saló G, Carreras R, Nogués X, Mellibovsky L, Díez-Pérez A, Grinberg D, Balcells S.
    J Bone Miner Res; 2008 Dec 27; 23(12):1954-63. PubMed ID: 18684085
    [Abstract] [Full Text] [Related]

  • 24. No association between hip geometry and four common polymorphisms associated with fracture: the Danish osteoporosis prevention study.
    Nissen N, Madsen JS, Bladbjerg EM, Beck Jensen JE, Jørgensen NR, Langdahl B, Abrahamsen B, Brixen K.
    Calcif Tissue Int; 2009 Apr 27; 84(4):276-85. PubMed ID: 19225709
    [Abstract] [Full Text] [Related]

  • 25. Genetic and environmental determinants of bone mineral density in Chinese women.
    Lau HH, Ng MY, Ho AY, Luk KD, Kung AW.
    Bone; 2005 Apr 27; 36(4):700-9. PubMed ID: 15781005
    [Abstract] [Full Text] [Related]

  • 26. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.
    Maturitas; 2006 Mar 20; 53(4):371-9. PubMed ID: 16139450
    [Abstract] [Full Text] [Related]

  • 27. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women.
    Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL.
    Bone; 2005 Apr 20; 36(4):599-606. PubMed ID: 15777745
    [Abstract] [Full Text] [Related]

  • 28. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
    Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R.
    J Clin Oncol; 2010 Feb 20; 28(6):967-75. PubMed ID: 20065185
    [Abstract] [Full Text] [Related]

  • 29. LRP5 gene polymorphisms and idiopathic osteoporosis in men.
    Ferrari SL, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis SE, Rizzoli R, de Vernejoul MC.
    Bone; 2005 Dec 20; 37(6):770-5. PubMed ID: 16168727
    [Abstract] [Full Text] [Related]

  • 30. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Zizic TM, Wallach S, Sewell KL, Lukert BP, Axelrod DW, Chines AA.
    Arthritis Rheum; 1999 Nov 20; 42(11):2309-18. PubMed ID: 10555025
    [Abstract] [Full Text] [Related]

  • 31. A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
    Boudin E, Steenackers E, de Freitas F, Nielsen TL, Andersen M, Brixen K, Van Hul W, Piters E.
    Bone; 2013 Apr 20; 53(2):414-20. PubMed ID: 23321396
    [Abstract] [Full Text] [Related]

  • 32. Association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density: a meta-analysis.
    Lee YH, Woo JH, Choi SJ, Ji JD, Song GG.
    Rheumatol Int; 2009 Mar 20; 29(5):539-44. PubMed ID: 18932002
    [Abstract] [Full Text] [Related]

  • 33. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep 20; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 34. Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.
    Riancho JA, Olmos JM, Pineda B, García-Ibarbia C, Pérez-Núñez MI, Nan DN, Velasco J, Cano A, García-Pérez MA, Zarrabeitia MT, González-Macías J.
    Eur J Endocrinol; 2011 Jan 20; 164(1):123-31. PubMed ID: 20926594
    [Abstract] [Full Text] [Related]

  • 35. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study.
    Ferrari SL, Karasik D, Liu J, Karamohamed S, Herbert AG, Cupples LA, Kiel DP.
    J Bone Miner Res; 2004 Apr 20; 19(4):552-9. PubMed ID: 15005841
    [Abstract] [Full Text] [Related]

  • 36. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K.
    J Rheumatol; 2010 Jan 20; 37(1):141-8. PubMed ID: 19918047
    [Abstract] [Full Text] [Related]

  • 37. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S, Klemes AB, Zhou X, Lindsay R.
    J Am Geriatr Soc; 2010 Apr 20; 58(4):658-63. PubMed ID: 20345865
    [Abstract] [Full Text] [Related]

  • 38. Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.
    Guadalix S, Martínez-Díaz-Guerra G, Lora D, Vargas C, Gómez-Juaristi M, Cobaleda B, González EM, Hawkins F.
    Transpl Int; 2011 Jul 20; 24(7):657-65. PubMed ID: 21466595
    [Abstract] [Full Text] [Related]

  • 39. [Association of polymorphism of low density lipoprotein receptor-related protein 5 Q89R, A1330V with bone mineral density in premenopausal northern Chinese women].
    Li Y, Sun CH, Yin H, Chen YF.
    Wei Sheng Yan Jiu; 2006 Sep 20; 35(5):576-9. PubMed ID: 17086708
    [Abstract] [Full Text] [Related]

  • 40. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men.
    Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS.
    J Korean Med Sci; 2004 Jun 20; 19(3):407-12. PubMed ID: 15201508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.